Why are you ballparking $10b when all of the examples given are many multiples of that? $100b seems like a better estimate.
I also suspect we’re targeting easy to eradicate diseases. Those without animal reservoirs that will cause resurgences and where there are effective interventions. Therefore, I’d suggest this is a lower bound.
I’m also confused as to why $10bn per disease is suggested, given the much higher costs of the listed examples.
However, it seems plausible that costs per disease will substantially decrease as we learn more about biology and how to successfully run eradication campaigns. For example, developing a new vaccine technology against one virus could make it much easier and cheaper to develop vaccines against related viruses.
Why are you ballparking $10b when all of the examples given are many multiples of that? $100b seems like a better estimate.
I also suspect we’re targeting easy to eradicate diseases. Those without animal reservoirs that will cause resurgences and where there are effective interventions. Therefore, I’d suggest this is a lower bound.
I’m also confused as to why $10bn per disease is suggested, given the much higher costs of the listed examples.
However, it seems plausible that costs per disease will substantially decrease as we learn more about biology and how to successfully run eradication campaigns. For example, developing a new vaccine technology against one virus could make it much easier and cheaper to develop vaccines against related viruses.